Evolution of tyrosinemia type 1 disease in patients treated with nitisinone in Spain
2019
AbstractTreatment with nitisinone (NTBC) has brought about a drastic improvement in the treatment and prognosis of hereditary tyrosinemia type I (HT1). We conducted a retrospective observational multicentric study in Spanish HT1 patients treated with NTBC to assess clinical and biochemical long-term
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
34
References
7
Citations
NaN
KQI